Cachexia Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 109 pages | ID: C6F47674FC1BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cachexia Treatment in Global, including the following market information:

Global Cachexia Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cachexia Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cachexia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cachexia Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cachexia Treatment Market Segment Percentages, By Type, 2020 (%)

• Weight Loss Stabilizers
• Appetite Stimulants
• Progestogens
• Corticosteroids
• Combination therapies
• Others

China Cachexia Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cachexia Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online

Global Cachexia Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cachexia Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cachexia Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cachexia Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Alder Biopharmaceuticals Inc.
• GTx Inc.
• Helsinn Group
• Merck & Co. Inc.
• Bristol-Myers Squibb Company
• Helsinn Healthcare S.A.
• PsiOxus
• Purdue Pharma L.P.
• Eterna Zentaris Inc.
• Aphios Corporation
• Neurim
• Novartis AG
• SkyePharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Osmotic Laxative Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Osmotic Laxative Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OSMOTIC LAXATIVE OVERALL MARKET SIZE

2.1 Global Osmotic Laxative Market Size: 2021 VS 2027
2.2 Global Osmotic Laxative Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Osmotic Laxative Players in Global Market
3.2 Top Global Osmotic Laxative Companies Ranked by Revenue
3.3 Global Osmotic Laxative Revenue by Companies
3.4 Top 3 and Top 5 Osmotic Laxative Companies in Global Market, by Revenue in 2020
3.5 Global Companies Osmotic Laxative Product Type
3.6 Tier 1, Tier 2 and Tier 3 Osmotic Laxative Players in Global Market
  3.6.1 List of Global Tier 1 Osmotic Laxative Companies
  3.6.2 List of Global Tier 2 and Tier 3 Osmotic Laxative Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Osmotic Laxative Market Size Markets, 2021 & 2027
  4.1.2 Lactulose
  4.1.3 Sorbitol
  4.1.4 Magnesium Citrate
  4.1.5 Milk of Magnesia
  4.1.6 Polyethylene Glycol
4.2 By Type - Global Osmotic Laxative Revenue & Forecasts
  4.2.1 By Type - Global Osmotic Laxative Revenue, 2016-2021
  4.2.2 By Type - Global Osmotic Laxative Revenue, 2022-2027
  4.2.3 By Type - Global Osmotic Laxative Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Osmotic Laxative Market Size, 2021 & 2027
  5.1.2 Drug Store
  5.1.3 Retail Pharmacies
  5.1.4 Hospital Pharmacies
  5.1.5 Online Pharmacies
5.2 By Application - Global Osmotic Laxative Revenue & Forecasts
  5.2.1 By Application - Global Osmotic Laxative Revenue, 2016-2021
  5.2.2 By Application - Global Osmotic Laxative Revenue, 2022-2027
  5.2.3 By Application - Global Osmotic Laxative Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Osmotic Laxative Market Size, 2021 & 2027
6.2 By Region - Global Osmotic Laxative Revenue & Forecasts
  6.2.1 By Region - Global Osmotic Laxative Revenue, 2016-2021
  6.2.2 By Region - Global Osmotic Laxative Revenue, 2022-2027
  6.2.3 By Region - Global Osmotic Laxative Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Osmotic Laxative Revenue, 2016-2027
  6.3.2 US Osmotic Laxative Market Size, 2016-2027
  6.3.3 Canada Osmotic Laxative Market Size, 2016-2027
  6.3.4 Mexico Osmotic Laxative Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Osmotic Laxative Revenue, 2016-2027
  6.4.2 Germany Osmotic Laxative Market Size, 2016-2027
  6.4.3 France Osmotic Laxative Market Size, 2016-2027
  6.4.4 U.K. Osmotic Laxative Market Size, 2016-2027
  6.4.5 Italy Osmotic Laxative Market Size, 2016-2027
  6.4.6 Russia Osmotic Laxative Market Size, 2016-2027
  6.4.7 Nordic Countries Osmotic Laxative Market Size, 2016-2027
  6.4.8 Benelux Osmotic Laxative Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Osmotic Laxative Revenue, 2016-2027
  6.5.2 China Osmotic Laxative Market Size, 2016-2027
  6.5.3 Japan Osmotic Laxative Market Size, 2016-2027
  6.5.4 South Korea Osmotic Laxative Market Size, 2016-2027
  6.5.5 Southeast Asia Osmotic Laxative Market Size, 2016-2027
  6.5.6 India Osmotic Laxative Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Osmotic Laxative Revenue, 2016-2027
  6.6.2 Brazil Osmotic Laxative Market Size, 2016-2027
  6.6.3 Argentina Osmotic Laxative Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Osmotic Laxative Revenue, 2016-2027
  6.7.2 Turkey Osmotic Laxative Market Size, 2016-2027
  6.7.3 Israel Osmotic Laxative Market Size, 2016-2027
  6.7.4 Saudi Arabia Osmotic Laxative Market Size, 2016-2027
  6.7.5 UAE Osmotic Laxative Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Osmotic Laxative Major Product Offerings
  7.1.4 Abbott Laboratories Osmotic Laxative Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories Key News
7.2 Bayer AG
  7.2.1 Bayer AG Corporate Summary
  7.2.2 Bayer AG Business Overview
  7.2.3 Bayer AG Osmotic Laxative Major Product Offerings
  7.2.4 Bayer AG Osmotic Laxative Revenue in Global (2016-2021)
  7.2.5 Bayer AG Key News
7.3 Procter & Gamble Company
  7.3.1 Procter & Gamble Company Corporate Summary
  7.3.2 Procter & Gamble Company Business Overview
  7.3.3 Procter & Gamble Company Osmotic Laxative Major Product Offerings
  7.3.4 Procter & Gamble Company Osmotic Laxative Revenue in Global (2016-2021)
  7.3.5 Procter & Gamble Company Key News
7.4 GlaxoSmithKline Consumer Healthcare
  7.4.1 GlaxoSmithKline Consumer Healthcare Corporate Summary
  7.4.2 GlaxoSmithKline Consumer Healthcare Business Overview
  7.4.3 GlaxoSmithKline Consumer Healthcare Osmotic Laxative Major Product Offerings
  7.4.4 GlaxoSmithKline Consumer Healthcare Osmotic Laxative Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline Consumer Healthcare Key News
7.5 Purdue Pharma
  7.5.1 Purdue Pharma Corporate Summary
  7.5.2 Purdue Pharma Business Overview
  7.5.3 Purdue Pharma Osmotic Laxative Major Product Offerings
  7.5.4 Purdue Pharma Osmotic Laxative Revenue in Global (2016-2021)
  7.5.5 Purdue Pharma Key News
7.6 Sucampo Pharmaceuticals Inc.
  7.6.1 Sucampo Pharmaceuticals Inc. Corporate Summary
  7.6.2 Sucampo Pharmaceuticals Inc. Business Overview
  7.6.3 Sucampo Pharmaceuticals Inc. Osmotic Laxative Major Product Offerings
  7.6.4 Sucampo Pharmaceuticals Inc. Osmotic Laxative Revenue in Global (2016-2021)
  7.6.5 Sucampo Pharmaceuticals Inc. Key News
7.7 Salix Pharmaceuticals
  7.7.1 Salix Pharmaceuticals Corporate Summary
  7.7.2 Salix Pharmaceuticals Business Overview
  7.7.3 Salix Pharmaceuticals Osmotic Laxative Major Product Offerings
  7.4.4 Salix Pharmaceuticals Osmotic Laxative Revenue in Global (2016-2021)
  7.7.5 Salix Pharmaceuticals Key News
7.8 Pharmos Corporation
  7.8.1 Pharmos Corporation Corporate Summary
  7.8.2 Pharmos Corporation Business Overview
  7.8.3 Pharmos Corporation Osmotic Laxative Major Product Offerings
  7.8.4 Pharmos Corporation Osmotic Laxative Revenue in Global (2016-2021)
  7.8.5 Pharmos Corporation Key News
7.9 Lexicon Pharmaceuticals
  7.9.1 Lexicon Pharmaceuticals Corporate Summary
  7.9.2 Lexicon Pharmaceuticals Business Overview
  7.9.3 Lexicon Pharmaceuticals Osmotic Laxative Major Product Offerings
  7.9.4 Lexicon Pharmaceuticals Osmotic Laxative Revenue in Global (2016-2021)
  7.9.5 Lexicon Pharmaceuticals Key News
7.10 Tioga Pharmaceuticals
  7.10.1 Tioga Pharmaceuticals Corporate Summary
  7.10.2 Tioga Pharmaceuticals Business Overview
  7.10.3 Tioga Pharmaceuticals Osmotic Laxative Major Product Offerings
  7.10.4 Tioga Pharmaceuticals Osmotic Laxative Revenue in Global (2016-2021)
  7.10.5 Tioga Pharmaceuticals Key News
7.11 Alimentary Health Limited
  7.11.1 Alimentary Health Limited Corporate Summary
  7.11.2 Alimentary Health Limited Business Overview
  7.11.3 Alimentary Health Limited Osmotic Laxative Major Product Offerings
  7.11.4 Alimentary Health Limited Osmotic Laxative Revenue in Global (2016-2021)
  7.11.5 Alimentary Health Limited Key News
7.12 Boehringer Ingelheim Pharmaceuticals Inc.
  7.12.1 Boehringer Ingelheim Pharmaceuticals Inc. Corporate Summary
  7.12.2 Boehringer Ingelheim Pharmaceuticals Inc. Business Overview
  7.12.3 Boehringer Ingelheim Pharmaceuticals Inc. Osmotic Laxative Major Product Offerings
  7.12.4 Boehringer Ingelheim Pharmaceuticals Inc. Osmotic Laxative Revenue in Global (2016-2021)
  7.12.5 Boehringer Ingelheim Pharmaceuticals Inc. Key News
7.13 Sucampo Pharmaceuticals, Inc.
  7.13.1 Sucampo Pharmaceuticals, Inc. Corporate Summary
  7.13.2 Sucampo Pharmaceuticals, Inc. Business Overview
  7.13.3 Sucampo Pharmaceuticals, Inc. Osmotic Laxative Major Product Offerings
  7.13.4 Sucampo Pharmaceuticals, Inc. Osmotic Laxative Revenue in Global (2016-2021)
  7.13.5 Sucampo Pharmaceuticals, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cachexia Treatment Market Opportunities & Trends in Global Market
Table 2. Cachexia Treatment Market Drivers in Global Market
Table 3. Cachexia Treatment Market Restraints in Global Market
Table 4. Key Players of Cachexia Treatment in Global Market
Table 5. Top Cachexia Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cachexia Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cachexia Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cachexia Treatment Product Type
Table 9. List of Global Tier 1 Cachexia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cachexia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cachexia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cachexia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cachexia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cachexia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cachexia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cachexia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cachexia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cachexia Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cachexia Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cachexia Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cachexia Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cachexia Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cachexia Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cachexia Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cachexia Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cachexia Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cachexia Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cachexia Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cachexia Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Alder Biopharmaceuticals Inc. Corporate Summary
Table 31. Alder Biopharmaceuticals Inc. Cachexia Treatment Product Offerings
Table 32. Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 33. GTx Inc. Corporate Summary
Table 34. GTx Inc. Cachexia Treatment Product Offerings
Table 35. GTx Inc. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Helsinn Group Corporate Summary
Table 37. Helsinn Group Cachexia Treatment Product Offerings
Table 38. Helsinn Group Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Merck & Co. Inc. Corporate Summary
Table 40. Merck & Co. Inc. Cachexia Treatment Product Offerings
Table 41. Merck & Co. Inc. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Bristol-Myers Squibb Company Corporate Summary
Table 43. Bristol-Myers Squibb Company Cachexia Treatment Product Offerings
Table 44. Bristol-Myers Squibb Company Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Helsinn Healthcare S.A. Corporate Summary
Table 46. Helsinn Healthcare S.A. Cachexia Treatment Product Offerings
Table 47. Helsinn Healthcare S.A. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 48. PsiOxus Corporate Summary
Table 49. PsiOxus Cachexia Treatment Product Offerings
Table 50. PsiOxus Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Purdue Pharma L.P. Corporate Summary
Table 52. Purdue Pharma L.P. Cachexia Treatment Product Offerings
Table 53. Purdue Pharma L.P. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Eterna Zentaris Inc. Corporate Summary
Table 55. Eterna Zentaris Inc. Cachexia Treatment Product Offerings
Table 56. Eterna Zentaris Inc. Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Aphios Corporation Corporate Summary
Table 58. Aphios Corporation Cachexia Treatment Product Offerings
Table 59. Aphios Corporation Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Neurim Corporate Summary
Table 61. Neurim Cachexia Treatment Product Offerings
Table 62. Neurim Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Novartis AG Corporate Summary
Table 64. Novartis AG Cachexia Treatment Product Offerings
Table 65. Novartis AG Cachexia Treatment Revenue (US$, Mn), (2016-2021)
Table 66. SkyePharma Corporate Summary
Table 67. SkyePharma Cachexia Treatment Product Offerings
Table 68. SkyePharma Cachexia Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Cachexia Treatment Segment by Type
Figure 2. Cachexia Treatment Segment by Application
Figure 3. Global Cachexia Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cachexia Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cachexia Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cachexia Treatment Revenue in 2020
Figure 8. By Type - Global Cachexia Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cachexia Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cachexia Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cachexia Treatment Revenue Market Share, 2016-2027
Figure 12. US Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cachexia Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cachexia Treatment Revenue Market Share, 2016-2027
Figure 24. China Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cachexia Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cachexia Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cachexia Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GTx Inc. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Helsinn Group Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck & Co. Inc. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bristol-Myers Squibb Company Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Helsinn Healthcare S.A. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. PsiOxus Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Purdue Pharma L.P. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eterna Zentaris Inc. Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Aphios Corporation Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Neurim Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Novartis AG Cachexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)